Pfizer (PFE)
25.77
-0.26 (-1.00%)
NYSE · Last Trade: Dec 8th, 5:45 PM EST
New York, NY – December 8, 2025 – A recent report from the Federal Reserve Bank of New York (New York Fed) reveals a concerning trend: U.S. households are growing increasingly pessimistic about their financial situations, even as inflation expectations remain largely stable. Released today, the November 2025 Survey of Consumer
Via MarketMinute · December 8, 2025
Market-based odds now show an 87% chance of a rate cut.
Via Stocktwits · December 8, 2025
Free cash flow is one of the most reliable indicators of financial durability.
These businesses not only generate cash but reinvest intelligently to sustain momentum.
Via StockStory · December 7, 2025
These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk?
Via The Motley Fool · December 5, 2025
Shares of biotechnology company Moderna (NASDAQ:MRNA)
jumped 6.4% in the afternoon session after a major long-term study from France indicated that its COVID-19 vaccine was safe and effective.
Via StockStory · December 5, 2025
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Via Chartmill · December 5, 2025
The rebound is well underway.
Via The Motley Fool · December 5, 2025
There is plenty to be wary of with this drugmaker, but there are also reasons to be optimistic.
Via The Motley Fool · December 5, 2025
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Via StockStory · December 5, 2025
Pfizer has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 11% to $25.67 per share while the index has gained 15.3%.
Via StockStory · December 4, 2025
The report added that at least one of these companies expects to fulfill the multi-billion-dollar investment pledge in full by Jan. 1, 2029.
Via Stocktwits · December 4, 2025
The global prescription drugs market is on the cusp of a significant expansion, with recent market reviews and forecasts projecting a robust growth trajectory through 2035. This anticipated surge, driven by an aging global population, the rising prevalence of chronic diseases, and relentless innovation in pharmaceutical research and development, signals
Via MarketMinute · December 3, 2025
December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an eight-year high. The dramatic ascent follows the announcement of overwhelmingly positive top-line results from its pivotal Phase 3 HOPE-3 study for
Via MarketMinute · December 3, 2025
Omaha, NE – December 3, 2025 – In a pivotal move set to redefine warfighter safety in hazardous environments, the National Strategic Research Institute (NSRI) at the University of Nebraska today officially launched a comprehensive, year-long study into emergent technologies designed to protect military personnel from the devastating effects of gamma radiation. This timely initiative, [...]
Via TokenRing AI · December 3, 2025
Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements.
Via Chartmill · December 3, 2025
Both AI giants might launch their public market offerings next year.
Via Stocktwits · December 3, 2025
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market attention.
Via Chartmill · December 2, 2025
These healthcare leaders can make you money while you sleep.
Via The Motley Fool · December 2, 2025
Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam.
Via Investor's Business Daily · December 2, 2025
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Via Chartmill · December 1, 2025
Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across an array of specialized and niche domains. Far from the public eye, AI is demonstrating unparalleled versatility, solving complex, previously intractable problems and delivering significant impact in areas ranging from accelerated drug [...]
Via TokenRing AI · December 1, 2025
Moderna tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children.
Via Investor's Business Daily · December 1, 2025
Rock-bottom prices don't always mean rock-bottom businesses.
The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
Via StockStory · December 1, 2025
New York, NY – December 1, 2025 – The S&P 500 has begun December 2025 with a notable decline, signaling a profound shift in market sentiment as investors grapple with a confluence of challenging economic factors. This downturn, described by analysts as "rediscovering gravity," comes after a period of sustained upward
Via MarketMinute · December 1, 2025